Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSE.L Regulatory News (LSE)

  • There is currently no data for LSE

Directorate Change

20 Nov 2020 10:46

RNS Number : 0293G
London Stock Exchange Group PLC
20 November 2020
 

20 November 2020

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

London Stock Exchange Group plc ("LSEG plc") Directorate changes & outcome of Euronext vote

Earlier today, shareholders in Euronext N.V. ("Euronext") approved the proposed acquisition of London Stock Exchange Group Holdings Italia S.p.A. ("LSEG Italia") together with its subsidiaries the ("Borsa Italiana Group") (the "Transaction").

In preparation for the proposed divestment of the Borsa Italiana Group to Euronext, Raffaele Jerusalmi and Andrea Sironi have agreed that it is now appropriate for them to step down from the LSEG plc Board with immediate effect.

Don Robert, Chair, LSEG:

"On behalf of the Board, I would like to thank Raffaele and Andrea for the tremendous contributions they have made both to the Group's success in Italy and more broadly. Raffaele, in the last 10 years in his role as an Executive Director, has played a key role in the growth of the Group's Capital Markets business since the merger between Borsa Italiana and London Stock Exchange in 2007. Following his appointment to the Board in 2016, Andrea has provided valuable financial risk management and regulatory experience. We wish them both the very best for the future."

- Ends -

Enquiries

For further information, please contact:

LSEG plc

 

Lucie Holloway, Rhiannon Davies (Media) 

+44 (0)20 7797 1222 

Paul Froud (Investors) 

+44 (0)20 7797 3322

Teneo (Communications Adviser to LSEG plc)

 

Lucas van Praag, Philip Gawith, Doug Campbell

+44 (0)20 7420 3183

 

 Appendix

The following information is provided pursuant to section 430(2B) of the Companies Act 2006.

Raffaele Jerusalmi

Mr Jerusalmi's employment by Borsa Italiana and LSEG Italia is unaffected by the termination of his LSEG directorship. As a consequence, no payments for loss of office will be made in connection with the cessation of his LSEG plc directorship.

Mr Jerusalmi will continue to receive his salary and contractual benefits from Borsa Italiana and LSEG Italia following the cessation of his directorship, on the terms described in LSEG's shareholder approved remuneration policy (the "Policy").

When Mr Jerusalmi leaves LSEG, upon completion of the proposed divestment of the Borsa Italiana Group to Euronext:

· Mr Jerusalmi (along with other employees leaving LSEG as a result of the divestment) will be treated as a 'good leaver' for the purposes of his interests in LSEG's share plans.

· Under the rules of LSEG's Long Term Incentive Plan ("LTIP"), LSEG's remuneration committee has discretion as to the timetable on which Mr Jerusalmi's outstanding LTIP awards will vest, as well as the application of any time pro-rating. A determination as to these matters will be made by the remuneration committee prior to completion of the proposed divestment. Further information on the treatment of the awards will be made available following such determination, in the 2020 Directors' Remuneration Report.

· Following vesting of Mr Jerusalmi's LTIP awards, the net resulting shares (after applicable withholdings) will be subject to a further two-year holding period, as set out in the Policy.

· Mr Jerusalmi will be entitled to an annual bonus for the 2020 financial year in the normal way. He will remain subject to LSEG's mandatory bonus deferral rules for any bonus awarded in respect of the 2020 financial year, and 50% will therefore be deferred into shares in accordance with the Policy.

· Mr Jerusalmi will be a good leaver in respect of any outstanding awards under LSEG's Deferred Bonus Plan ("DBP"). In accordance with the DBP rules and the Policy, those awards will vest, without time pro-rating, on their planned vesting date. Mr Jerusalmi currently holds DBP awards over 11,342 shares, granted in 2019 and 2020.

· Mr Jerusalmi will be subject, in accordance with the Policy, to a two-year post-employment shareholding requirement equivalent to three times his base salary as at the date of completion of the proposed divestment.

Andrea Sironi

Mr Sironi will not receive any payment for loss of office in connection with the cessation of his LSEG plc directorship. He will continue to receive fees from Borsa Italiana and LSEG Italia in connection with his ongoing directorships of those entities.

 

This announcement is made on behalf of LSEG plc by Lisa Condron, the Group Company Secretary of LSEG plc.

 

Further information

 

No offer of securities

 

This announcement does not constitute or form part of any offer or invitation to purchase, acquire, subscribe for, sell, dispose of or issue, or any solicitation of any offer to sell, dispose of, purchase, acquire or subscribe for, any security, including any LSEG plc shares.

 

Forward-looking statements

 

This announcement, oral statements made regarding the Transaction, and other information published in connection with the Transaction, contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. The forward-looking statements contained in this announcement include statements relating to the expected timing and scope of the Transaction and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved.

 

Although LSEG plc believes that the expectations reflected in such forward-looking statements are reasonable, LSEG plc can give no assurance that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include the satisfaction of the conditions to the Transaction, as well as factors such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as changes in the political, social and regulatory framework, or in economic or technological trends or conditions. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. Such forward-looking statements should therefore be construed in the light of such factors.

 

None of LSEG plc or any of its associates or directors, officers or advisers provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place undue reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations (including under the Listing Rules, the Disclosure Guidance and Transparency Rules and the Prospectus Regulation Rules of the FCA), LSEG plc is under no obligation, and LSEG plc expressly disclaims any intention or obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Transaction conditions

 

Completion of the Transaction is subject to the satisfaction of a number of conditions as more fully described in the Circular. Consequently, there can be no certainty that completion of the Transaction will be forthcoming.

 

Defined terms

 

Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the Circular.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABGBDBSSDDGGG
Date   Source Headline
29th Jul 20197:00 amRNSStatement re Press Comment
17th Jul 20199:00 amRNSDirectorate Change
1st Jul 20194:46 pmRNSTotal Voting Rights
1st May 20191:33 pmRNSResult of AGM
1st May 201910:34 amRNSAGM Statement
1st May 20197:00 amRNSTrading Statement
2nd Apr 201910:03 amRNSCapital Markets Division Leadership
1st Apr 201910:32 amRNSBlock listing Interim Review
1st Apr 201910:27 amRNSTotal Voting Rights
28th Mar 20194:01 pmRNSDirector/PDMR Shareholding
25th Mar 20194:01 pmRNSDirector/PDMR Shareholding
22nd Mar 201910:17 amRNSAnnual Financial Report
20th Mar 20191:41 pmRNSDirector/PDMR Shareholding
13th Mar 20192:35 pmRNSDirector/PDMR Shareholding
8th Mar 201910:52 amRNSDirectorate Change
1st Mar 20197:00 amRNSAnnual Financial Report
30th Jan 20197:00 amRNSAcquisition of stake
22nd Jan 201910:37 amRNSInformation Services Division Management Changes
2nd Jan 201910:25 amRNSTotal Voting Rights
28th Dec 201812:44 pmRNSDirectorate Change
14th Dec 20182:43 pmRNSDirectorate Change
14th Dec 20189:24 amRNSAcquisition
4th Dec 20183:44 pmRNSPublication of Final Terms Replacement
4th Dec 20182:58 pmRNSPublication of Final Terms
22nd Nov 201811:21 amRNSDirector/PDMR Shareholding
21st Nov 201811:28 amRNSDirectorate Change
19th Oct 20187:01 amRNS3rd Quarter Trading Statement
19th Oct 20187:00 amRNSAcquisition
11th Oct 20181:10 pmRNSDirectorate Change
5th Oct 20183:36 pmRNSDirector/PDMR Shareholding
1st Oct 20182:57 pmRNSBlock listing Interim Review
1st Oct 20182:56 pmRNSTotal Voting Rights
26th Sep 201810:03 amRNSHolding(s) in Company
25th Sep 201810:23 amRNSDirectorate Change
24th Sep 20183:23 pmRNSHolding(s) in Company
3rd Sep 201810:03 amRNSTotal Voting Rights
9th Aug 20189:22 amRNSDirector/PDMR Shareholding
8th Aug 20184:09 pmRNSDirector/PDMR Shareholding
2nd Aug 20187:00 amRNSHalf-year Report
2nd Jul 201810:00 amRNSDirector Declaration
18th May 201811:28 amRNSDirector/PDMR Shareholding
1st May 20183:46 pmRNSTotal Voting Rights
26th Apr 20183:43 pmRNSDirector/PDMR Shareholding
24th Apr 20182:58 pmRNSResult of AGM
24th Apr 201810:31 amRNSAGM Statement
24th Apr 20187:00 amRNSTrading Statement
18th Apr 20185:29 pmRNSDirector/PDMR Shareholding
13th Apr 20183:00 pmRNSDirector Declaration
13th Apr 20187:00 amRNSDirectorate Change
11th Apr 20182:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.